<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28808027</article-id>
<article-id pub-id-type="pmc">5584457</article-id>
<article-id pub-id-type="publisher-id">201709255</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1709255114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Medical Sciences</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>De novo mutations in inhibitors of Wnt, BMP, and Ras/ERK signaling pathways in non-syndromic midline craniosynostosis</article-title>
<alt-title alt-title-type="short">De novo mutations in midline craniosynostosis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Timberlake</surname>
<given-names>Andrew T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Furey</surname>
<given-names>Charuta G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Jungmin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nelson-Williams</surname>
<given-names>Carol</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<collab>Yale Center for Genome Analysis</collab>
<xref ref-type="fn" rid="fn2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loring</surname>
<given-names>Erin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galm</surname>
<given-names>Amy</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kahle</surname>
<given-names>Kristopher T.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steinbacher</surname>
<given-names>Derek M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Larysz</surname>
<given-names>Dawid</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Persing</surname>
<given-names>John A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lifton</surname>
<given-names>Richard P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>3</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Genetics, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff2"><sup>b</sup>Section of Plastic and Reconstructive Surgery, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff3"><sup>c</sup>Department of Neurosurgery, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06510;</aff>
<aff id="aff4"><sup>d</sup><institution>Craniosynostosis and Positional Plagiocephaly Support</institution>, New York, <addr-line>NY</addr-line> 10010;</aff>
<aff id="aff5"><sup>e</sup>Department of Radiotherapy, <institution>The Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology</institution>, 44-101 Gliwice, <country>Poland</country>;</aff>
<aff id="aff6"><sup>f</sup>Laboratory of Human Genetics and Genomics, <institution>The Rockefeller University</institution>, New York, NY 10065</aff>
</contrib-group>
<contrib-group content-type="collaborators">
<contrib contrib-type="collab">
<name>
<surname>Bilguvar</surname>
<given-names>Kaya</given-names>
</name>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Mane</surname>
<given-names>Shrikant</given-names>
</name>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Tikhonova</surname>
<given-names>Irina</given-names>
</name>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Castaldi</surname>
<given-names>Christopher</given-names>
</name>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Knight</surname>
<given-names>James</given-names>
</name>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>3</sup>To whom correspondence should be addressed. Email: <email>rickl@mail.rockefeller.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Contributed by Richard P. Lifton, July 13, 2017 (sent for review June 6, 2017; reviewed by Yuji Mishina and Jay Shendure)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: A.T.T., J.A.P., and R.P.L. designed research; A.T.T., C.G.F., C.N.-W., and Y.C.G.A. performed research; E.L., A.G., K.T.K., D.M.S., D.L., and J.A.P. conducted patient recruitment; A.T.T., J.C., and R.P.L. analyzed data; and A.T.T. and R.P.L. wrote the paper.</p>
</fn>
<fn fn-type="con">
<p>Reviewers: Y.M., University of Michigan; and J.S., University of Washington.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>C.G.F., J.C., and C.N.-W. contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p>Conflict of interest statement: J.S. and R.P.L. were among 42 coauthors on a 2015 review article.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>29</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>8</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>114</volume>
<issue>35</issue>
<fpage>E7341</fpage>
<lpage>E7347</lpage>
<permissions>
<license license-type="open-access">
<license-p>Freely available online through the PNAS open access option.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201709255.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Craniosynostosis is a common congenital malformation resulting from premature fusion of the bones that comprise the cranial vault, requiring surgery in infancy to prevent adverse neurologic outcomes. Eighty-five percent of cases are non-syndromic and of unknown cause. By exome sequencing of families with non-syndromic midline craniosynostosis, we show that 5% of cases have de novo damaging mutations in negative regulators of the Wnt, bone morphogenetic protein (BMP), and Ras/ERK signaling pathways, developmental cascades that converge on common nuclear targets to promote bone formation. Another 5% have transmitted mutations in these pathways. Common variants near <italic>BMP2</italic> show genetic interaction with these rare mutations. The results provide insight into pathophysiology and have immediate implications for the diagnosis and genetic counseling of families with craniosynostosis.</p>
</abstract>
<abstract>
<p>Non-syndromic craniosynostosis (NSC) is a frequent congenital malformation in which one or more cranial sutures fuse prematurely. Mutations causing rare syndromic craniosynostoses in humans and engineered mouse models commonly increase signaling of the Wnt, bone morphogenetic protein (BMP), or Ras/ERK pathways, converging on shared nuclear targets that promote bone formation. In contrast, the genetics of NSC is largely unexplored. More than 95% of NSC is sporadic, suggesting a role for de novo mutations. Exome sequencing of 291 parent–offspring trios with midline NSC revealed 15 probands with heterozygous damaging de novo mutations in 12 negative regulators of Wnt, BMP, and Ras/ERK signaling (10.9-fold enrichment, <italic>P</italic> = 2.4 × 10<sup>−11</sup>). <italic>SMAD6</italic> had 4 de novo and 14 transmitted mutations; no other gene had more than 1. Four familial NSC kindreds had mutations in genes previously implicated in syndromic disease. Collectively, these mutations contribute to 10% of probands. Mutations are predominantly loss-of-function, implicating haploinsufficiency as a frequent mechanism. A common risk variant near <italic>BMP2</italic> increased the penetrance of <italic>SMAD6</italic> mutations and was overtransmitted to patients with de novo mutations in other genes in these pathways, supporting a frequent two-locus pathogenesis. These findings implicate new genes in NSC and demonstrate related pathophysiology of common non-syndromic and rare syndromic craniosynostoses. These findings have implications for diagnosis, risk of recurrence, and risk of adverse neurodevelopmental outcomes. Finally, the use of pathways identified in rare syndromic disease to find genes accounting for non-syndromic cases may prove broadly relevant to understanding other congenital disorders featuring high locus heterogeneity.</p>
</abstract>
<kwd-group>
<kwd>de novo mutation</kwd>
<kwd>craniosynostosis</kwd>
<kwd>BMP signaling</kwd>
<kwd>Wnt signaling</kwd>
<kwd>Ras/ERK signaling</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">Yale Center for Mendelian Genomics</funding-source>
<award-id rid="sp1">NIH M#UM1HG006504-05</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">NIH Medical Scientist Training Program</funding-source>
<award-id rid="sp2">NIH/NIGMS T32GM007205</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">Howard Hughes Medical Institute (HHMI)<named-content content-type="funder-id">100000011</named-content></funding-source>
<award-id rid="sp3">-</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>